Top compounds associated with response to ARHGEF26


Feature Type Standardized
Nominal ANOVA
mRNA cediranib CTRPv2 pan-cancer AAC 0.057 0.3
mRNA Erlotinib CCLE pan-cancer AAC -0.047 0.3
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.062 0.3
mRNA Dasatinib FIMM pan-cancer AAC 0.17 0.3
mRNA thapsigargin gCSI pan-cancer AAC 0.061 0.3
mRNA CAY10594 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC 0.047 0.3
mRNA Erlotinib FIMM pan-cancer AAC 0.17 0.3
Download CSV